Notably, these authors included in their analysis only randomized controlled trials with a duration 52 weeks considering that interventions shorter than that were unlikely to affect the fracture risk [13]
Despite this shared mechanism, they differ significantly in receptor selectivity, GH pulse profile, and co-secreted hormones differences that substantially affect which compound is appropriate for different research questions
This translates to earlier improvements in blood sugar, liver enzymes, and inflammatory markers
GLP-1 is a relatively new entrant to a weight loss market in the U.S
In the United States, However, a generic drug can be marketed only after the brand-name drugs patent has expired, taking up to 20 years after the patent holders drug is first filed with the FDA